Overexpression of c-Myc Alters G₁/S Arrest following Ionizing Radiation

REFERENCES

• Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92: 8493–8497.
   PubMed Web of Science ®Google Scholar
• Bacus, S. S., Y. Yarden, M. Oren, D. M. Chin, L. Lyass, C. R. Zelnick, A. Kazarov, W. Toyofuku, J. Gray-Bablin, R. R. Beerli, N. E. Hynes, M. Nikiforov, R. Haffner, A. Gudkov, and K. Keyomarsi. 1996. Neu differentiation factor (heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 12: 2535–2547.
   PubMed Web of Science ®Google Scholar
• Berns, K., E. M. Hijmans, and R. Bernards. 1997. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene 15: 1347–1356.
   PubMedGoogle Scholar
• Blackwood, E. M., B. Luscher, L. Kretzner, and R. N. Eisenman. 1991. The Myc:Max protein complex and cell growth regulation. Cold Spring Harbor Symp. Quant. Biol. 56: 109–117.
   PubMedGoogle Scholar
• Bunz, F., A. Dutriaux, C. Lengauer, T. Waldman, S. Zhou, J. P. Brown, J. M. Sedivy, K. W. Kinzler, and B. Vogelstein. 1998. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501.
   PubMed Web of Science ®Google Scholar
• Cahill, D. P., K. W. Kinzler, B. Vogelstein, and C. Lengauer. 1999. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 9: M57-M60.
   PubMed Web of Science ®Google Scholar
• Claassen, G. F., and S. R. Hann. 2000. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc. Natl. Acad. Sci. USA 97: 9498–9503.
   PubMed Web of Science ®Google Scholar
• Coller, H. A., C. Grandori, P. Tamayo, T. Colbert, E. S. Lander, R. N. Eisenman, and T. R. Golub. 2000. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 97: 3260–3265.
   PubMed Web of Science ®Google Scholar
• Dang, C. V., L. M. Resar, E. Emison, S. Kim, Q. Li, J. E. Prescott, D. Wonsey, and K. Zeller. 1999. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253: 63–77.
   PubMed Web of Science ®Google Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
   PubMed Web of Science ®Google Scholar
• Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8: 2540–2551.
   PubMed Web of Science ®Google Scholar
• Di Leonardo, A., S. P. Linke, Y. Yin, and G. M. Wahl. 1993. Cell cycle regulation of gene amplification. Cold Spring Harbor Symp. Quant. Biol. 58: 655–667.
   PubMedGoogle Scholar
• el-Deiry, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169–1174.
   PubMed Web of Science ®Google Scholar
• Facchini, L. M., S. Chen, W. W. Marhin, J. N. Lear, and L. Z. Penn. 1997. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol. 17: 100–114.
   PubMed Web of Science ®Google Scholar
• Facchini, L. M., and L. Z. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633–651.
   PubMed Web of Science ®Google Scholar
• Felsher, D. W., and J. M. Bishop. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl. Acad. Sci. USA 96: 3940–3944.
   PubMed Web of Science ®Google Scholar
• Felsher, D. W., A. Zetterberg, J. Zhu, T. Tlsty, and J. M. Bishop. 2000. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc. Natl. Acad. Sci. USA 97: 10544–10548.
   PubMed Web of Science ®Google Scholar
• Forrester, H. B., N. Albright, C. C. Ling, and W. C. Dewey. 2000. Computerized video time-lapse analysis of apoptosis of REC:Myc cells X-irradiated in different phases of the cell cycle. Radiat. Res. 154: 625–639.
   PubMedGoogle Scholar
• Gandarillas, A., and F. M. Watt. 1997. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev. 11: 2869–2882.
   PubMed Web of Science ®Google Scholar
• Gudas, J., H. Nguyen, T. Li, D. Hill, and K. H. Cowan. 1995. Effects of cell cycle, wild-type p53 and DNA damage on p21CIP1/Waf1 expression in human breast epithelial cells. Oncogene 11: 253–261.
   PubMed Web of Science ®Google Scholar
• Hanson, K. D., M. Shichiri, M. R. Follansbee, and J. M. Sedivy. 1994. Effects of c-myc expression on cell cycle progression. Mol. Cell. Biol. 14: 5748–5755.
   PubMedGoogle Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816.
   PubMed Web of Science ®Google Scholar
• Harrington, E. A., J. L. Bruce, E. Harlow, and N. Dyson. 1998. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl. Acad. Sci. USA 95: 11945–11950.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543–546.
   PubMed Web of Science ®Google Scholar
• Hirst, S. K., and C. Grandori. 2000. Differential activity of conditional MYC and its variant MYC-S in human mortal fibroblasts. Oncogene 19: 5189–5197.
   PubMedGoogle Scholar
• Jansen-Durr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90: 3685–3689.
   PubMed Web of Science ®Google Scholar
• Khan, S. H., J. Moritsugu, and G. M. Wahl. 2000. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl. Acad. Sci. USA 97: 3266–3271.
   PubMedGoogle Scholar
• Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84–88.
   PubMed Web of Science ®Google Scholar
• Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396: 643–649.
   PubMed Web of Science ®Google Scholar
• Li, Q., and C. V. Dang. 1999. c-Myc overexpression uncouples DNA replication from mitosis. Mol. Cell. Biol. 19: 5339–5351.
   PubMedGoogle Scholar
• Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23: 1686–1690.
   PubMed Web of Science ®Google Scholar
• Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923–935.
   PubMed Web of Science ®Google Scholar
• Liyanage, M., A. Coleman, S. du Manoir, T. Veldman, S. McCormack, R. B. Dickson, C. Barlow, A. Wynshaw-Boris, S. Janz, J. Wienberg, M. A. Ferguson-Smith, E. Schrock, and T. Ried. 1996. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet. 14: 312–315.
   PubMed Web of Science ®Google Scholar
• Loeb, L. A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51: 3075–3079.
   PubMed Web of Science ®Google Scholar
• Mai, S. 1994. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase. Gene 148: 253–260.
   PubMed Web of Science ®Google Scholar
• Mai, S., M. Fluri, D. Siwarski, and K. Huppi. 1996. Genomic instability in MycER-activated Rat1A-MycER cells. Chromosome Res. 4: 365–371.
   PubMed Web of Science ®Google Scholar
• McCormack, S. J., Z. Weaver, S. Deming, G. Natarajan, J. Torri, M. D. Johnson, M. Liyanage, T. Ried, and R. B. Dickson. 1998. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. Oncogene 16: 2755–2766.
   PubMed Web of Science ®Google Scholar
• McKenna, W. G., G. Iliakis, M. C. Weiss, E. J. Bernhard, and R. J. Muschel. 1991. Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125: 283–287.
   PubMed Web of Science ®Google Scholar
• Merlo, G. R., F. Basolo, L. Fiore, L. Duboc, and N. E. Hynes. 1995. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J. Cell Biol. 128: 1185–1196.
   PubMed Web of Science ®Google Scholar
• Meyer, K. M., S. M. Hess, T. D. Tlsty, and S. A. Leadon. 1999. Human mammary epithelial cells exhibit a differential p53-mediated response following exposure to ionizing radiation or UV light. Oncogene 18: 5795–5805.
   PubMedGoogle Scholar
• Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-986, 989.
   PubMed Web of Science ®Google Scholar
• Mitchell, K. O., and W. S. El-Deiry. 1999. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10: 223–230.
   PubMedGoogle Scholar
• Nass, S. J., and R. B. Dickson. 1998. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Clin. Cancer Res. 4: 1813–1822.
   PubMed Web of Science ®Google Scholar
• Paulovich, A. G., D. P. Toczyski, and L. H. Hartwell. 1997. When checkpoints fail. Cell 88: 315–321.
   PubMed Web of Science ®Google Scholar
• Perez-Roger, I., D. L. Solomon, A. Sewing, and H. Land. 1997. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14: 2373–2381.
   PubMed Web of Science ®Google Scholar
• Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4: 57–65.
   PubMedGoogle Scholar
• Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12: 5581–5592.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102: 407–410.
   PubMed Web of Science ®Google Scholar
• Soule, H. D., T. M. Maloney, S. R. Wolman, W. D. J. Peterson, R. Brenz, C. M. McGrath, J. Russo, R. J. Pauley, R. F. Jones, and S. C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6075–6086.
   PubMed Web of Science ®Google Scholar
• Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17: 1459–1468.
   PubMedGoogle Scholar
• Stampfer, M. R., and J. C. Bartley. 1985. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 82: 2394–2398.
   PubMed Web of Science ®Google Scholar
• Stampfer, M. R., C. H. Pan, J. Hosoda, J. Bartholomew, J. Mendelsohn, and P. Yaswen. 1993. Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp. Cell Res. 208: 175–188.
   PubMedGoogle Scholar
• Tait, L., H. D. Soule, and J. Russo. 1990. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50: 6087–6094.
   PubMed Web of Science ®Google Scholar
• Valverius, E. M., F. Ciardiello, N. E. Heldin, B. Blondel, G. Merlo, G. Smith, M. R. Stampfer, M. E. Lippman, R. B. Dickson, and D. S. Salomon. 1990. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T. J. Cell Physiol. 145: 207–216.
   PubMedGoogle Scholar
• Vidair, C. A., C. H. Chen, C. C. Ling, and W. C. Dewey. 1996. Apoptosis induced by X-irradiation of rec-myc cells is postmitotic and not predicted by the time after irradiation or behavior of sister cells. Cancer Res. 56: 4116–4118.
   PubMedGoogle Scholar
• Wahl, G. M., S. P. Linke, T. G. Paulson, and L. C. Huang. 1997. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29: 183–219.
   PubMedGoogle Scholar
• Waldman, T., K. W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55: 5187–5190.
   PubMed Web of Science ®Google Scholar
• Waldman, T., C. Lengauer, K. W. Kinzler, and B. Vogelstein. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713–716.
   PubMed Web of Science ®Google Scholar
• Weaver, Z. A., S. J. McCormack, M. Liyanage, S. du Manoir, A. Coleman, E. Schrock, R. B. Dickson, and T. Ried. 1999. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice. Genes Chromosomes Cancer 25: 251–260.
   PubMed Web of Science ®Google Scholar
• Wei, W., R. M. Hemmer, and J. M. Sedivy. 2001. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21: 6748–6757.
   PubMedGoogle Scholar
• Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704.
   PubMed Web of Science ®Google Scholar
• Yin, X. Y., L. Grove, N. S. Datta, M. W. Long, and E. V. Prochownik. 1999. c-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18: 1177–1184.
   PubMedGoogle Scholar
• Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937–948.
   PubMed Web of Science ®Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12: 2424–2433.
   PubMed Web of Science ®Google Scholar